Torrado C, Nassif Haddad E, Somaiah N, Msaouel P, Lazar A, Piha-Paul S
    
    
    J Immunother Precis Oncol. 2025; 8(2):113-120.
  
  
    PMID: 40070529
    
          PMC: 11896019.
    
          DOI: 10.36401/JIPO-24-28.
      
 
                                  
  
    Torchia A, Vari S, Onesti C, Ceddia S, Maschio M, Maggi G
    
    
    Front Pharmacol. 2025; 16:1512966.
  
  
    PMID: 40061960
    
          PMC: 11885513.
    
          DOI: 10.3389/fphar.2025.1512966.
      
 
                                  
  
    Remiszewski P, Gaik W, Skora A, Waz J, Filipek K, Pisklak A
    
    
    Med Oncol. 2025; 42(4):94.
  
  
    PMID: 40056309
    
    
          DOI: 10.1007/s12032-025-02651-2.
      
 
                                  
  
    Graberg T, Papakonstantinou A, de Flon F, Shabo I, Morgell A, Linder-Straglitto C
    
    
    Rare Tumors. 2025; 17:20363613251324973.
  
  
    PMID: 40026783
    
          PMC: 11869257.
    
          DOI: 10.1177/20363613251324973.
      
 
                                  
  
    Roets E, Younger E, Jones R, Hollander D, Desar I, Young R
    
    
    Support Care Cancer. 2025; 33(3):228.
  
  
    PMID: 40011242
    
          PMC: 11865148.
    
          DOI: 10.1007/s00520-025-09248-5.
      
 
                              
              
                              
                                      
  Nab-Paclitaxel Based Chemotherapy in the Treatment of Advanced Epithelioid Hemangioendothelioma: A Single-Institution Experience.
  
    Liu X, Yang P, Liu L, Si S, Zhou R, Liu T
    
    
    Cancer Manag Res. 2025; 17:373-381.
  
  
    PMID: 40007912
    
          PMC: 11853918.
    
          DOI: 10.2147/CMAR.S508673.
      
 
                                          
                                                          
  Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched Analysis.
  
    Berclaz L, Jurinovic V, Burkhard-Meier A, Abdel-Rahman S, Albertsmeier M, Klein A
    
    
    Cancer Med. 2025; 14(4):e70655.
  
  
    PMID: 40007213
    
          PMC: 11861570.
    
          DOI: 10.1002/cam4.70655.
      
 
                                          
                                                          
  The Impact of Surgical Margin Distance on Local Recurrence and Survival in Patients with Soft Tissue Sarcoma.
  
    Yurtbay A, Aydin Simsek S, Cengiz T, Baris Y, Say F, Dabak N
    
    
    Medicina (Kaunas). 2025; 61(2).
  
  
    PMID: 40005406
    
          PMC: 11857427.
    
          DOI: 10.3390/medicina61020289.
      
 
                                          
                                                          
  Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches.
  
    Costa A, Astolfi A, Gozzellino L, Nannini M, Pasquinelli G, Pantaleo M
    
    
    Biomolecules. 2025; 15(2).
  
  
    PMID: 40001568
    
          PMC: 11852613.
    
          DOI: 10.3390/biom15020265.
      
 
                                          
                                                          
  Rethinking tumor viability as prognostic factor in soft tissue sarcoma.
  
    Montreuil J, Kholodovsky E, Markowitz M, Torralbas Fitz S, Campano D, Erik Geiger J
    
    
    J Orthop. 2025; 68:7-14.
  
  
    PMID: 39980706
    
          PMC: 11836483.
    
          DOI: 10.1016/j.jor.2025.01.030.
      
 
                                          
                                                          
  Improved Quantification of Circulating Tumor DNA in Translocation-Associated Myxoid Liposarcoma by Simultaneous Detection of Breakpoints and Single Nucleotide Variants.
  
    Schmid A, Lausch U, Runkel A, Kiefer J, Pauli T, Boerries M
    
    
    Cancer Med. 2025; 14(4):e70704.
  
  
    PMID: 39980272
    
          PMC: 11842865.
    
          DOI: 10.1002/cam4.70704.
      
 
                                          
                                                          
  Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors.
  
    Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, Studer G, Fuchs B
    
    
    Cancers (Basel). 2025; 17(3).
  
  
    PMID: 39941878
    
          PMC: 11816265.
    
          DOI: 10.3390/cancers17030510.
      
 
                                          
                                                          
  Principles of Surgical Treatment of Soft Tissue Sarcomas.
  
    Gonzalez M, Mendez-Guerra C, Goh M, Pretell-Mazzini J
    
    
    Cancers (Basel). 2025; 17(3).
  
  
    PMID: 39941773
    
          PMC: 11816134.
    
          DOI: 10.3390/cancers17030401.
      
 
                                          
                                                          
  "Modernized" en Bloc Radical Cystectomy Versus Standard Radical Cystectomy: A Nationwide Multi-Institutional Propensity Score Matched Analysis.
  
    Kjobli E, Haug E, Salvesen O, Arstad C, Bergesen A, Brennhovd B
    
    
    Cancers (Basel). 2025; 17(3).
  
  
    PMID: 39941772
    
          PMC: 11816131.
    
          DOI: 10.3390/cancers17030404.
      
 
                                          
                                                          
  Safety and efficacy analysis of ultrasound-guided microwave ablation for pediatric recurrent aggressive fibromatosis.
  
    Zhang H, Lv L, Li X, Huang S, Zhao Z, Kong X
    
    
    J Orthop Surg Res. 2025; 20(1):157.
  
  
    PMID: 39940026
    
          PMC: 11823254.
    
          DOI: 10.1186/s13018-025-05563-z.
      
 
                                          
                                                          
  High expression level of ERBB2 and efficacy of trastuzumab deruxtecan in desmoplastic small round cell tumour: a monocentric case series report.
  
    Brahmi M, Vanacker H, Dufresne A, Isnardi V, Dupont M, Meurgey A
    
    
    ESMO Open. 2025; 10(2):104133.
  
  
    PMID: 39921935
    
          PMC: 11850745.
    
          DOI: 10.1016/j.esmoop.2025.104133.
      
 
                                          
                                                          
  Evaluating ChatGPT-4o as a decision support tool in multidisciplinary sarcoma tumor boards: heterogeneous performance across various specialties.
  
    Ammo T, Guillaume V, Hofmann U, Ulmer N, Buenting N, Laenger F
    
    
    Front Oncol. 2025; 14:1526288.
  
  
    PMID: 39896191
    
          PMC: 11782276.
    
          DOI: 10.3389/fonc.2024.1526288.
      
 
                                          
                                                          
  Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians.
  
    Kruiswijk A, Vlug L, Acem I, Engelhardt E, Gronchi A, Callegaro D
    
    
    Ann Surg Oncol. 2025; 32(4):2958-2970.
  
  
    PMID: 39893340
    
          PMC: 11882627.
    
          DOI: 10.1245/s10434-024-16849-7.
      
 
                                          
                                                          
  Progress in personalized immunotherapy for patients with brain metastasis.
  
    Patel L, Kolundzic N, Abedalthagafi M
    
    
    NPJ Precis Oncol. 2025; 9(1):31.
  
  
    PMID: 39880875
    
          PMC: 11779815.
    
          DOI: 10.1038/s41698-025-00812-0.
      
 
                                          
                                                          
  ASO Author Reflections: Enhancing Shared Decision-Making with Risk Prediction Models in Sarcoma Care.
  
    van Bodegom-Vos L, Kruiswijk A, van de Sande M
    
    
    Ann Surg Oncol. 2025; 32(4):2981-2982.
  
  
    PMID: 39878843
    
          PMC: 11882700.
    
          DOI: 10.1245/s10434-025-16970-1.